Pheochromocytoma

CHICAGO — In rare hereditary cancers such as paraganglioma/pheochromocytoma, where patients travel for their care, COVID caused a disruption in their screening and treatments, according to a poster presented during ASCO Annual Meeting.

Unrecognized and untreated pheochromocytoma in women before or during pregnancy was associated with a substantially higher risk for maternal or fetal complications, according to data from a retrospective study.

Long-term treatment regimens for neuroendocrine neoplasms can be safely and temporarily delayed in the setting of life-threatening COVID-19-related symptoms, which should be “urgently treated,” according to new guidance.

More than half of a cohort of children and young adults with multiple endocrine neoplasia type 2B had restrictive and obstructive lung abnormalities and 94% showed some degree of diminished lung function, NIH study data showed.

Endocrine Today has compiled a list of the top recent news reports focused on neuroendocrinology and adrenal medicine.

Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral fracture, a hallmark of osteoporosis, when compared with adults with nonfunctional adrenal tumors, according to findings published in Bone.

CHICAGO — There are a number of gaps in the 2017 American Heart Association/American College of Cardiology hypertension guideline that cardiologists may not be aware of, presenters said at the Cardiometabolic Health Congress.

Adults with bilateral pheochromocytomas treated with cortical-sparing adrenalectomy were less likely to need steroid replacement therapy and had a low risk for tumor recurrence over 8 years when compared with similar patients who underwent total bilateral adrenalectomy, according to a retrospective database analysis published in JAMA Network Open.